KRRO Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
-100.0%
1.3M
+18.5%
1.1M
-25.3%
1.5M
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
-100.0%
1.3M
+18.5%
1.1M
-25.3%
1.5M
Operating Expenses
20.1M
-1.6%
20.4M
-60.5%
51.7M
+154.3%
20.3M
-29.1%
28.7M
R&D
13.6M
+4.9%
13.0M
+17.9%
11.0M
-20.5%
13.8M
-31.4%
20.1M
SG&A
6.5M
-12.9%
7.5M
+20.9%
6.2M
-4.9%
6.5M
-10.8%
7.3M
Operating Income
-20110000
+1.6%
-20436000
+59.4%
-50396000
-162.0%
-19237000
+29.3%
-27202000
EBITDA
-19745000
+1.6%
-20056000
-31.7%
-15234000
+15.6%
-18058000
+27.0%
-24742000
Net Income
-18916000
+3.6%
-19625000
+60.8%
-50042000
-177.1%
-18061000
+29.9%
-25770000
EPS (Basic)
$-1.07
+36.7%
$-1.69
+68.2%
$-5.31
-176.6%
$-1.92
+29.9%
$-2.74
EPS (Diluted)
$-1.07
+36.7%
$-1.69
+68.2%
$-5.31
-176.6%
$-1.92
+29.9%
$-2.74
Shares (Diluted)
17.6M
+51.9%
11.6M
+23.2%
9.4M
+0.3%
9.4M
+0.0%
9.4M
Korro Bio (KRRO) โ€” Financials